The care about smokers after acute coronary syndromes: An overlooked emergency;La prise en charge des fumeurs au décours d'un syndrome coronaire aigu: Une «urgence» négligée

Archives des Maladies du Coeur et des Vaisseaux

Volumn 100, Issue 6-7, 2007, Pages 509-511

  Thomas, D ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ACUTE CORONARY SYNDROME; ADULT; CARDIOVASCULAR DISEASE; EDITORIAL; HUMAN; MAJOR CLINICAL STUDY; NICOTINE REPLACEMENT THERAPY; QUESTIONNAIRE; RECURRENCE RISK; RETROSPECTIVE STUDY; SMOKING; SMOKING CESSATION;

CORONARY DISEASE; HUMANS; MYOCARDIAL INFARCTION; NICOTINIC AGONISTS; RISK FACTORS; SMOKING; SMOKING CESSATION; SURVIVAL RATE; TOBACCO USE DISORDER;

EID: 34547816710     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. Teo KK, Ounpuu S, Hawken S, on behalf of the INTERHEART study investigators. Tobacco use and risk of myocardial infarction in fifty two countries in the INTERHEART study : a case-control study. Lancet 2006 ; 368 : 647-58.
2. Marques-Vidal, Cambou JP, Ferrières J, Thomas D, Grenier O, Cantet C, Danchin N. Distribution et prise en charge des facteurs de risque cardiovasculaires chez des patients coronariens : Étude PREVENIR. Arch Mal Coeur 2001 ; 94 : 673-80.
3. Critchley JA, Capwell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease. A systematic review. JAMA 2003: 290 ; 86-97.
4. Quist-Paulsen P, Lydersen S, Bakke PS, Gallefoss F. Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease. Eur J Cardiovasc Prev Rehabil 2006, 13 : 274-80.
5. Scholte op Reimer W, de Swart E, De Bacquer D. for the EUROASPIRE investigators. Smoking behaviour in European patients with established coronary heart disease. Eur Heart J 2006 ; 27 : 35-41.
6. Mahmarian JJ, Moye LA, Nasser GA et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise induced myocardial ischemia. J Am Coll Cardiol 1997 ; 30 : 125-30.
7. Meine TJ, Patel MR Washam JB, Pappas PA, Jollis JG. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005 ; 95 : 976-8.
8. AFSSAPS (Agence Française de Sécuríté Sanitaire des Produits de Santé). Les stratégies thérapeutiques médicamenteuses et non médicamenteuses de l'aide à l'arrêt du tabac. Recommandations de bonne pratique. ai 2003. http://afssaps.sante.fr/htm/10/tabac/sommaire.htm
9. Guevel-Jointret A, Borel ML, Munier S, Cornily JC, Pennec PY, Gilard M, Mansourati J. Tolérance et efficacité de la substitution nicotinique précoce au décours d'un syndrome coronaire aigu. Arch Mal Cœur 2007 ; 100 : 514-8.
10. Taylor CB, Houston-Miller N, Killen JD, De Busk RF. Smoking cessation after myocardial infarction. Effects of a nurse-managed intervention. Ann Int Med 1990 ; 113 : 118-23.
11. Van Berkel TFM, Boersma H, Roos-Hesseliink JW, Erdman RAM, Simoons ML. Impact of smoking, cessation and smoking interventions in patients with coronary heart disease. Eur Heart J 1999 ; 20 : 1773-82.
12. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist vs placebo or sustained-release bupropion for smoking cessation : a randomized controlled trial. JAMA 2006 ; 296 : 56-63.